Cargando…
Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking
BACKGROUND: Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor are efficacious for the prevention of migraine headaches. The downstream molecular mechanisms following ligand-receptor blockade by which these antibodies prevent CGRP signaling through CGRP receptors ha...
Autores principales: | Manoukian, Raffi, Sun, Hong, Miller, Silke, Shi, Di, Chan, Brian, Xu, Cen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734291/ https://www.ncbi.nlm.nih.gov/pubmed/31039731 http://dx.doi.org/10.1186/s10194-019-0992-1 |
Ejemplares similares
-
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
por: Cohen, Fred, et al.
Publicado: (2022) -
Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines
por: Katsuki, Masahito, et al.
Publicado: (2023) -
Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021) -
Eptinezumab: A calcitonin gene-related peptide monoclonal antibody
infusion for migraine prevention
por: Morgan, Kelsey Woods, et al.
Publicado: (2021) -
How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
por: Tiseo, Cindy, et al.
Publicado: (2019)